Skip to main content

Inspection visit

Health inspection

GRANDE OAKSCMS #3658252 citations on this visit
2 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 2 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0760 Ensure that residents are free from significant medication errors. Level of Harm - Minimal harm or potential for actual harm **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to ensure a controlled substance medication was administered per physician orders. This affected one resident (#21) out of three residents reviewed for medication administration. This had the potential to affect fifteen residents (#1, #4, #8, #10, #11, #13, #17, #21, #26, #29, #31, #33, #37, #45, and #47) who were ordered controlled substance medication. The facility census was 48. Residents Affected - Few Findings include: Review of the medical record for Resident #21 revealed an admission date of 02/03/24. Diagnosis included acute respiratory failure with hypoxia, chronic diastolic (congestive) heart failure, depression, history of transient ischemic attack (TIA), chronic obstructive pulmonary disease (COPD), type II diabetes mellitus, asthma, anxiety disorder, and atrial fibrillation. Review of the 5-day Minimal Data Set (MDS) assessment dated [DATE] revealed Resident #21 had intact cognition. Review of the physician orders dated February 2024 revealed an order for Alprazolam (brand name Xanax) 0.25 milligram (mg) (anti-anxiety medication) give one tablet every twelve hours as needed for anxiety for fourteen days. Resident #21 did not have an order for Ambien (controlled medication, sedative). Review of the Resident #21's Medication Administration Records (MAR) for February 2024 revealed on 02/19/24 Xanax 0.25 mg had a blank spot. Review of the late entry progress note dated 02/19/24 revealed Resident #21 received Zolpidem (Ambien) 5 mg after stating she needed an as needed (PRN) medication. Interview on 03/12/24 at 6:49 A.M. with Licensed Practical Nurse (LPN) #172 (night nurse) revealed on 02/19/24 she discovered Resident #21 received the wrong medication. LPN #172 reported the resident received Ambien instead of Alprazolam. LPN #172 reported she notified the physician and Resident #21's daughter (who is a nurse at the facility - LPN #158). LPN #172 reported LPN #158 (daughter) helped pull the wrong medication from the starter kit with a second nurse, LPN #164, who administered the Ambien instead of the ordered Alprazolam. Interview on 03/12/24 at 8:17 A.M. with LPN #158 revealed Resident #21 was administered Ambien instead of Alprazolam for anxiety on 02/19/24. (LPN #158 is also the daughter of Resident #21). LPN #158 reported LPN #164 pulled the wrong medication and she witnessed it. LPN #158 thought Alprazolam was (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 3 Event ID: 365825 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365825 B. Wing A. Building (X3) DATE SURVEY COMPLETED 03/21/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Grande Oaks 24579 Broadway Ave Oakwood Village, OH 44146 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few pulled, when she found out later it was Ambien that was pulled from the starter kit. LPN #158 reported LPN #164 administered the Ambien to Resident #21 instead of Alprazolam. Interview on 03/14/24 at 8:44 A.M. with Pharmacist #214 revealed she was notified by the Assistant Director of Nursing (ADON) on 02/20/24 that the wrong medication, Ambien was pulled in error instead of Xanax. Pharmacist #214 reported once notified on their end, a report was documented, and Ambien medication was replaced in the starter kit. Pharmacist #214 reported no one from pharmacy needed to come to the facility since it was self-reported. Pharmacist #214 verified Ambien and Xanax are both controlled substances, category 4 classification. Ambien is a sedative and Xanax is an antianxiety medication. Interview on 03/14/24 at 10:03 A.M. with LPN #164 revealed on 02/19/24 Resident #21 requested Xanax. LPN #164 reported she had to pull the medication from the starter kit. LPN #164 reported LPN #158 got the authorization from pharmacy to pull two Alprazolam from the starter kit. LPN #164 reported LPN #158 pulled what they thought was Alprazolam from the starter kit. LPN #164 reported she witnessed and signed for the medication. LPN #158 reported definitely an error on my part for sure LPN #164 reported she administered Ambien instead of Alprazolam to Resident #21. LPN #164 reported she was notified by LPN #172 (night shift nurse) that the wrong medication was pulled. LPN #172 notified LPN #164 they pulled Ambien from the starter kit and not Alprazolam (as ordered). Interview on 03/14/24 at 10:49 A.M. with the Director of Nursing (DON) revealed he was notified on 02/19/24 in the evening by LPN #172 regarding Resident #21 administering the wrong medication. The DON reported Resident #21 was administered Ambien instead of the ordered Xanax. The DON reported he started an investigation immediately. The DON reported neither LPN #158 nor LPN #164 verified the correct medication was pulled and administered. The DON reported pharmacy was notified the next day regarding the medication error and asked to replace the Ambien pulled from the starter kit. The DON reported education was provided. Review of the medication error report dated February 19, 2024, at 3:34 P.M. revealed an error without harm had occurred. Review of the incident report dated 02/19/24 included inter department team made aware of medication error with Ambien being administered for anxiety. Authorization to pull Xanax from starter box received from pharmacy, nurse pulled Zolpidem instead. No negative effects were noted. The incident was reported to physician. Education was provided to the nurse. The family and resident were notified. Review of the Request for Removal of Controlled Drug Substances (CDS) Medication From The Emergency Box/Starter Box revealed authorization from pharmacy was given to pull Alprazolam (Xanax) 0.25 mg, quantity two. Authorization was signed by LPN #158. This deficiency represents non-compliance investigated under Complaint Number OH00151466. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 365825 If continuation sheet Page 2 of 3 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365825 B. Wing A. Building (X3) DATE SURVEY COMPLETED 03/21/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Grande Oaks 24579 Broadway Ave Oakwood Village, OH 44146 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Safeguard resident-identifiable information and/or maintain medical records on each resident that are in accordance with accepted professional standards. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review, interview, and facility policy review the facility failed to ensure a controlled substance was documented after administered per physician's orders. This affected one resident (#21) out of three residents reviewed for medication administration. This had the potential to affect fifteen residents (#1, #4, #8, #10, #11, #13, #17, #21, #26, #29, #31, #33, #37, #45, and #47) who were ordered controlled substance medication. The facility census was 48. Findings include: Review of the medical record for Resident #21 revealed an admission date of 02/03/24. Diagnosis included acute respiratory failure with hypoxia, chronic diastolic (congestive) heart failure, depression, history of transient ischemic attack (TIA), chronic obstructive pulmonary disease (COPD), type II diabetes mellitus, asthma, anxiety disorder, and atrial fibrillation. Review of the 5-day Minimal Data Set (MDS) assessment dated [DATE] revealed Resident #21 had intact cognition. Review of the physician orders dated February 2024 revealed an order for Alprazolam (brand name Xanax) 0.25 milligram (mg) (anti-anxiety medication) give one tablet every twelve hours as needed for anxiety for fourteen days. Review of the Resident #21's Medication Administration Records (MAR) for February 2024 revealed for 02/19/24 Xanax 0.25 mg had a blank spot. Interview on 03/12/24 at 6:49 A.M. with Licensed Practical Nurse (LPN) #172 (night nurse) verified after medication administration you were to sign off on the MAR that the medication was administered with your initials. Interview on 03/12/24 at 8:17 A.M. with LPN #158 verified after medication administration you are to sign off in the MAR that the medication was administered with your initials. LPN #158 verified Resident #21 (her mom) received medication. Interview on 03/14/24 at 10:03 A.M. with LPN #164 verified on 02/19/24 she forgot to sign the MAR after administering Xanax 0.25 mg to Resident #21. LPN #164 verified she did not sign off the MAR with her initials because she forgot to do it. Interview on 03/14/24 at 10:49 A.M. with the Director of Nursing (DON) verified after medication administration you are to sign off in the MAR the medication was administered with your initials. The DON verified the medication was not signed off. Review of the facility policy, Documentation in Medical Record, dated 09/01/22, revealed documentation shall be completed at the time of service and record date, time of entry, and sign each entry with name and credentials. This deficiency was an incidental finding identified during the complaint investigation. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 365825 If continuation sheet Page 3 of 3

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

2 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0760GeneralS&S Dpotential for harm

    F760 - Residents are free of any significant medication errors

    Ensure that residents are free from significant medication errors.

  • 0842GeneralS&S Dpotential for harm

    F842 - Resident-identifiable information

    Safeguard resident-identifiable information and/or maintain medical records on each resident that are in accordance with accepted professional standards.

FAQ · About this visit

Common questions about this visit

What happened during the March 21, 2024 survey of GRANDE OAKS?

This was a inspection survey of GRANDE OAKS on March 21, 2024. The surveyor cited 2 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at GRANDE OAKS on March 21, 2024?

Yes, 2 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Ensure that residents are free from significant medication errors."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.